Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5265 USD | -5.27% | +0.80% | -3.09% |
03-22 | Sangamo Therapeutics Prices $24 Million Registered Direct Offering | MT |
03-14 | Sangamo Therapeutics Pushes Neurology Programs Toward Clinical Development, Wedbush Says | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.09% | 115M | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- SGMO Stock
- News Sangamo Therapeutics, Inc.
- Wedbush Adjusts Sangamo Therapeutics' Price Target to $4 From $5 After Increase in Share Count, Keeps Neutral Rating